|
Market Closed -
Nasdaq
16:00:00 2026-09-29 EDT
|
5-day change | 1st Jan Change | ||
| 1.360 USD | -2.16% |
|
-3.55% | -18.07% |
| 07-28 | SNDL Shares Fall After Q2 Swings to Adjusted Operating Loss, Revenue Declines | MT |
| 07-28 | Tranche Update on SNDL Inc.'s Equity Buyback Plan announced on November 4, 2025. | CI |
| Market Cap | 482M 339M 300M 283M 257M 32.57B 487M 3.4B 1.31B 16.63B 1.27B 1.25B 53.52B | P/E 2026 * |
-22.8x | P/E 2027 * | 194x |
|---|---|---|---|---|---|
| Enterprise Value | 482M 339M 300M 283M 257M 32.57B 487M 3.4B 1.31B 16.63B 1.27B 1.25B 53.52B | EV / Sales 2026 * |
0.53x | EV / Sales 2027 * | 0.52x |
| Free-Float |
98.31% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SNDL | Delayed | |
CBOE
| SNDL | Real-time | |
|
Canadian Securities Exchange
| SNDL | Delayed | |
|
Börse Stuttgart
| VY4 | Delayed | |
|
Deutsche Boerse AG
| VY4 | Delayed | |
|
Tradegate
| VY4 | Real-time | |
|
Boerse Muenchen
| VY4 | Real-time |
Last Transcript: SNDL Inc.
| 1 day | -2.16% | ||
| 1 week | -3.55% | ||
| Current month | -0.73% | ||
| 1 month | +0.37% | ||
| 3 months | -1.45% | ||
| 6 months | +3.82% | ||
| Current year | -18.07% |
| 1 week | 1.36 |  | 1.42 |
| 1 month | 1.33 | | 1.46 |
| Current year | 1.16 | | 1.82 |
| 1 year | 1.16 | | 2.89 |
| 3 years | 1.15 | | 2.93 |
| 5 years | 1.15 | | 9.6 |
| 10 years | 1.15 | | 132.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary George
CEO | Chief Executive Officer | 48 | 2020-01-29 |
| Director of Finance/CFO | 53 | 2023-06-30 | |
Phil McBride
CTO | Chief Tech/Sci/R&D Officer | 52 | 2024-11-20 |
| Director | Title | Age | Since |
|---|---|---|---|
Gregory Turnbull
BRD | Director/Board Member | 71 | 2018-09-30 |
Greg Mills
CHM | Chairman | 63 | 2019-05-31 |
Zachary George
BRD | Director/Board Member | 48 | 2019-11-26 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/16/26 | Option | Director | 29,939 | 0.0121% | ||
| 9/16/26 | Option | Chairman | 38,256 | 0.0154% | ||
| 9/16/26 | Option | Director | 14,970 | 0.0060% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.16% | -3.55% | -50.36% | -28.42% | 346M | |
| -0.01% | +1.24% | +63.06% | +120.55% | 1,056B | |
| -1.61% | -0.60% | +47.32% | +71.79% | 655B | |
| -1.12% | -0.72% | +17.98% | +76.63% | 471B | |
| -1.72% | -4.25% | +37.79% | +39.89% | 342B | |
| -0.40% | +4.12% | +22.89% | +29.04% | 277B | |
| -0.51% | -1.05% | +12.98% | +12.92% | 257B | |
| +1.32% | +3.27% | +54.63% | +57.63% | 226B | |
| -0.61% | -0.91% | +34.33% | +101.87% | 189B | |
| -0.24% | -3.21% | -27.79% | -61.37% | 170B | |
| Average | -0.71% | +0.18% | +21.28% | +42.05% | 364.32B | |
| Weighted average by Cap. | -0.63% | +0.76% | +39.19% | +70.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 909M 641M 565M 535M 485M 61.46B 918M 6.42B 2.47B 31.39B 2.41B 2.35B 101B | 925M 651M 575M 544M 493M 62.5B 934M 6.52B 2.51B 31.91B 2.45B 2.39B 103B |
| Net income | -21.59M -15.2M -13.42M -12.7M -11.51M -1.46B -21.8M -152M -58.7M -745M -57.09M -55.85M -2.4B | 2.1M 1.48M 1.31M 1.23M 1.12M 142M 2.12M 14.81M 5.71M 72.46M 5.55M 5.43M 233M |
| Net Debt | - | - |
Employees
2,751
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-29 | US$1.360 | -2.16% | 1,945,782 |
| 26-09-28 | US$1.390 | -0.71% | 727,083 |
| 26-09-25 | US$1.400 | 0.00% | 689,897 |
| 26-09-24 | US$1.400 | 0.00% | 1,521,877 |
| 26-09-23 | US$1.400 | -0.71% | 665,471 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.969CAD
Average target price
4.932CAD
Spread / Average Target
+150.46%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SNDL Stock
Select your edition
All financial news and data tailored to specific country editions
